Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Controlled release of triamcinolone acetonide from polyurethane implantable devices: application for inhibition of inflammatory-angiogenesis.

Pinto FC, Da Silva-Cunha Junior A, Oréfice RL, Ayres E, Andrade SP, Lima LD, Moura SA, Da Silva GR.

J Mater Sci Mater Med. 2012 Jun;23(6):1431-45. doi: 10.1007/s10856-012-4615-5. Epub 2012 Apr 1.

PMID:
22466817
2.

Local drug delivery system: inhibition of inflammatory angiogenesis in a murine sponge model by dexamethasone-loaded polyurethane implants.

Moura SA, Lima LD, Andrade SP, Da Silva-Cunha A Jr, Órefice RL, Ayres E, Da Silva GR.

J Pharm Sci. 2011 Jul;100(7):2886-95. doi: 10.1002/jps.22497. Epub 2011 Jan 31.

PMID:
21283986
3.

Biodegradable scleral implants as new triamcinolone acetonide delivery systems.

Felt-Baeyens O, Eperon S, Mora P, Limal D, Sagodira S, Breton P, Simonazzi B, Bossy-Nobs L, Guex-Crosier Y, Gurny R.

Int J Pharm. 2006 Sep 28;322(1-2):6-12. Epub 2006 Jun 2.

PMID:
16824708
4.

Intraocular sustained-release delivery systems for triamcinolone acetonide.

Mansoor S, Kuppermann BD, Kenney MC.

Pharm Res. 2009 Apr;26(4):770-84. doi: 10.1007/s11095-008-9812-z. Epub 2009 Jan 28. Review.

PMID:
19184374
5.

Development and characterization of novel polyurethane films impregnated with tolfenamic acid for therapeutic applications.

Istanbullu H, Ahmed S, Sheraz MA, Ihtesham ur Rehman.

Biomed Res Int. 2013;2013:178973. doi: 10.1155/2013/178973. Epub 2013 Sep 1.

6.

Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-ε-caprolactone matrix.

Meng Y, Sun S, Li J, Nan K, Lan B, Jin Y, Chen H, Cheng L.

Acta Biomater. 2014 Jan;10(1):126-33. doi: 10.1016/j.actbio.2013.09.022. Epub 2013 Sep 27.

PMID:
24076072
7.

Controlled release of dexamethasone acetate from biodegradable and biocompatible polyurethane and polyurethane nanocomposite.

Da Silva GR, Ayres E, Orefice RL, Moura SA, Cara DC, Cunha Ada S Jr.

J Drug Target. 2009 Jun;17(5):374-83. doi: 10.1080/10611860902839510.

PMID:
19555266
8.

Effect of the macromolecular architecture of biodegradable polyurethanes on the controlled delivery of ocular drugs.

da Silva GR, da Silva Cunha A Jr, Ayres E, Oréfice RL.

J Mater Sci Mater Med. 2009 Feb;20(2):481-7. doi: 10.1007/s10856-008-3607-y. Epub 2008 Oct 14.

PMID:
18853235
9.

Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.

Chen M, Li X, Liu J, Han Y, Cheng L.

J Control Release. 2015 Apr 10;203:109-17. doi: 10.1016/j.jconrel.2015.02.021. Epub 2015 Feb 17.

PMID:
25700623
10.

Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.

Sabzevari A, Adibkia K, Hashemi H, De Geest BG, Mohsenzadeh N, Atyabi F, Ghahremani MH, Khoshayand MR, Dinarvand R.

Invest Ophthalmol Vis Sci. 2013 Aug 15;54(8):5520-6. doi: 10.1167/iovs.13-12296.

PMID:
23833065
11.

Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.

Li W, He B, Dai W, Zhang Q, Liu Y.

Int Ophthalmol. 2014 Jun;34(3):465-76. doi: 10.1007/s10792-013-9829-0. Epub 2013 Jul 19.

PMID:
23868505
12.

Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL).

Sun S, Li J, Li X, Lan B, Zhou S, Meng Y, Cheng L.

Acta Biomater. 2016 Jun;37:143-54. doi: 10.1016/j.actbio.2016.04.014. Epub 2016 Apr 9.

PMID:
27071973
13.

Development of thalidomide-loaded biodegradable devices and evaluation of the effect on inhibition of inflammation and angiogenesis after subcutaneous application.

Pereira BG, Batista LF, de Souza PA, da Silva GR, Andrade SP, Serakides R, da Nova Mussel W, Silva-Cunha A, Fialho SL.

Biomed Pharmacother. 2015 Apr;71:21-8. doi: 10.1016/j.biopha.2015.02.003. Epub 2015 Feb 19.

PMID:
25960210
14.

Drug delivery implants in the treatment of vitreous inflammation.

Wang J, Jiang A, Joshi M, Christoforidis J.

Mediators Inflamm. 2013;2013:780634. doi: 10.1155/2013/780634. Epub 2013 Sep 28. Review.

15.

Anti-Inflammatory Effect of Dexamethasone Controlled Released From Anterior Suprachoroidal Polyurethane Implants on Endotoxin-Induced Uveitis in Rats.

Barbosa Saliba J, Vieira L, Fernandes-Cunha GM, Rodrigues Da Silva G, Ligório Fialho S, Silva-Cunha A, Bousquet E, Naud MC, Ayres E, Oréfice RL, Tekaya M, Kowalczuk L, Zhao M, Behar-Cohen F.

Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1671-9. doi: 10.1167/iovs.15-18127.

PMID:
27054520
16.

Self-assembled aliphatic chain extended polyurethane nanobiohybrids: emerging hemocompatible biomaterials for sustained drug delivery.

Mishra A, Singh SK, Dash D, Aswal VK, Maiti B, Misra M, Maiti P.

Acta Biomater. 2014 May;10(5):2133-46. doi: 10.1016/j.actbio.2013.12.035. Epub 2013 Dec 25.

PMID:
24374322
17.

Fractional Laser Ablation for the Cutaneous Delivery of Triamcinolone Acetonide from Cryomilled Polymeric Microparticles: Creating Intraepidermal Drug Depots.

Singhal M, Del Río-Sancho S, Sonaje K, Kalia YN.

Mol Pharm. 2016 Feb 1;13(2):500-11. doi: 10.1021/acs.molpharmaceut.5b00711. Epub 2016 Jan 15.

PMID:
26731121
18.

Physicochemical characterization and in vivo evaluation of triamcinolone acetonide-loaded hydroxyapatite nanocomposites for treatment of rheumatoid arthritis.

Jafari S, Maleki-Dizaji N, Barar J, Barzegar-Jalali M, Rameshrad M, Adibkia K.

Colloids Surf B Biointerfaces. 2016 Apr 1;140:223-232. doi: 10.1016/j.colsurfb.2015.12.050. Epub 2015 Dec 31.

PMID:
26764105
19.

Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells.

Kambhampati SP, Mishra MK, Mastorakos P, Oh Y, Lutty GA, Kannan RM.

Eur J Pharm Biopharm. 2015 Sep;95(Pt B):239-49. doi: 10.1016/j.ejpb.2015.02.013. Epub 2015 Feb 19.

20.

Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis.

Guo D, Li Q, Sun Y, Guo J, Zhao Q, Yin X, Wei H, Wu S, Bi H.

Nanotechnology. 2019 Apr 19;30(16):165702. doi: 10.1088/1361-6528/aafe36. Epub 2019 Jan 14.

PMID:
30641491

Supplemental Content

Support Center